Table 3.

Characteristics of recovery studies (n = 112).

Characteristics of study	Ayurveda (n = 66)	Yoga & Naturopathy (n = 1)	Unani (n = 3)	Siddha (n = 18)	Homeopathy (n = 14)	Others (n = 6)	Collaborative (n = 4)
Treatment arms
Single arm	12	0	0	4	4	0	0
Double arm	49	1	2	13	9	6	4
Multi arm	5	0	1	1	1	0	0
Sample size
≤30	10	0	0	1	0	1	2
31–100	35	0	2	11	9	3	2
101–1000	21	1	1	6	5	2	0
Study Population
Only Asymptomatic Positive	2	0	0	2	3	0	0
Asymptomatic Positive & Mild to moderate infection	15	1	1	7	3	2	2
Mild to moderate	49	0	2	9	8	4	2
Type of Intervention (where applicable)
Single drug formulation	5	0	1	1	7	1	0
Multi drug formulation	34	0	2	10	3	2	0
Multi-formulation regimen	27	0	0	7	1	3	4
Not Specified	0	0	0	0	3	0	0
Non-Pharmacological	0	1	0	0	0	0	0
Type of Comparators (where applicable)
AYUSH vs. CC	24	1	0	8	1	1	3
AYUSH vs. Placebo/No Treatment	7	0	3	1	2	0	0
AYUSH vs. nutritional/dietary items	3	0	0	3	0	0	0
AYUSH + CC vs.CC or Placebo + CC	20	0	0	2	7	5	1
Treatment duration
≤7 days	4	0	0	4	2	0	0
>7 days to ≤15 days	29	1	2	10	2	6	4
>15 days to ≤30 days	12	0	0	0	2	0	0
>30 days	3	0	0	2	0	0	0
Not Specified	18	0	1	2	8	0	0
Primary Outcomes
Clearance from infection (Symptomatic, Clinical, serological)	47	0	1	11	11	2	2
Progression of severity of infection	19	1	2	7	3	4	2
Study Duration
≤3 months	26	0	2	11	9	2	3
>3 moths & ≤ 6 months	32	1	1	7	4	3	0
>6 months & ≤ 1 year	8	0	0	0	1	1	1
>1 year	0	0	0	0	0	0	0